Age-related penetrance of the C9orf72 repeat expansion

Scientific Reports
Natalie A MurphyBryan J Traynor

Abstract

A pathogenic hexanucleotide repeat expansion within the C9orf72 gene has been identified as the major cause of two neurodegenerative syndromes, amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). This mutation is known to have incomplete penetrance, with some patients developing disease in their twenties and a small portion of carriers surviving to their ninth decade without developing symptoms. Describing penetrance by age among C9orf72 carriers and identifying parameters that alter onset age are essential to better understanding this locus and to enhance predictive counseling. To do so, data from 1,170 individuals were used to model penetrance. Our analysis showed that the penetrance was incomplete and age-dependent. Additionally, familial and sporadic penetrance did not significantly differ from one another; ALS cases exhibited earlier age of onset than FTD cases; and individuals with spinal-onset exhibited earlier age of onset than those with bulbar-onset. The older age of onset among female cases in general, and among female bulbar-onset cases in particular, was the most striking finding, and there may be an environmental, lifestyle, or hormonal factor that is influencing these penetrance patterns. These...Continue Reading

References

Jan 1, 1991·Neuroepidemiology·A ChióD Schiffer
Jan 31, 2007·Neurology·D HirtzR Zalutsky
Jul 20, 2007·Journal of Neurology, Neurosurgery, and Psychiatry·O O'TooleO Hardiman
Aug 31, 2010·Lancet Neurology·Hannu LaaksovirtaBryan J Traynor
Mar 1, 2012·Brain : a Journal of Neurology·Johnathan Cooper-KnockPamela J Shaw
Dec 21, 2012·Journal of Alzheimer's Disease : JAD·Isabelle Le BerAlexis Brice
Feb 6, 2013·Clinical Genetics·M SabatelliM Zollino
May 1, 2015·Expert Review of Pharmacoeconomics & Outcomes Research·Matthew Gladman, Lorne Zinman
Jun 29, 2016·Molecular Neurobiology·Maria Sara Cipolat MisStefania Corti
Aug 12, 2016·Nature Communications·Karissa C ArthurBryan J Traynor

❮ Previous
Next ❯

Citations

Jul 7, 2018·Current Genetic Medicine Reports·Nimansha Jain, Alice S Chen-Plotkin
Apr 12, 2019·Annals of Neurology·Ana WestenbergerChristine Klein
Jun 10, 2019·Annals of Neurology·Giorgia QuerinUNKNOWN Predict to Prevent Frontotemporal Lobar Degeneration and Amyotrophic Lateral Sclerosis Study Group
Nov 28, 2019·Current Neurology and Neuroscience Reports·Hannah E SilvermanEdward D Huey
Jul 27, 2018·Neurology·Adriano ChiòAmmar Al-Chalabi
Apr 22, 2020·Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration·Michelle B OffitTanya J Lehky
May 10, 2020·Neurogenetics·Jay P RossGuy A Rouleau
Feb 13, 2020·Current Opinion in Neurology·Olivier Piguet, Fiona Kumfor
Oct 2, 2020·Continuum : Lifelong Learning in Neurology·Colin Quinn, Lauren Elman
Sep 21, 2018·Frontiers in Psychology·David FoxeOlivier Piguet
Nov 28, 2018·Acta Neuropathologica·Gaël Nicolas, Joris A Veltman
Dec 24, 2019·Frontiers in Neuroscience·Rita MejziniP Anthony Akkari
May 18, 2020·Journal of Molecular Neuroscience : MN·E Srinivasan, R Rajasekaran
May 28, 2020·International Journal of Molecular Sciences·Francesca TrojsiGioacchino Tedeschi
Mar 28, 2019·Frontiers in Neuroscience·Elisabetta ZucchiJessica Mandrioli
Mar 18, 2020·Brain Imaging and Behavior·Francesca CasoMassimo Filippi
Sep 27, 2018·Brain : a Journal of Neurology·Ming ZhangUNKNOWN International FTD-Genomics Consortium (IFGC)
May 24, 2019·Journal of Neurology·Caroline V Greaves, Jonathan D Rohrer
Mar 26, 2019·Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration·Ashley CrookDominic B Rowe
Nov 21, 2020·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·Kamen A TsvetanovUNKNOWN Genetic FTD Initiative, GENFI
Dec 31, 2020·Human Molecular Genetics·Amrutha PattamattaLaura P W Ranum
Jan 10, 2021·Neurobiology of Aging·Rebecca E WaughMary Kay Floeter
Jul 29, 2020·Clinics in Laboratory Medicine·Jennifer Roggenbuck, Jamie C Fong
Sep 23, 2020·Cortex; a Journal Devoted to the Study of the Nervous System and Behavior·Mira DidicOlivier Felician
Sep 6, 2020·Neurobiology of Disease·Suvi HäkkinenSuzee E Lee
May 9, 2021·Journal of Medical Genetics·Lauren M CairnsAndrew G L Douglas
May 25, 2021·Frontiers in Cellular Neuroscience·Julie SmeyersMorwena Latouche
Jul 3, 2021·International Journal of Molecular Sciences·Isabella ZanellaEugenia Quiros-Roldan
May 20, 2021·Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration·Sara Llamas-VelascoAlberto Villarejo-Galende

❮ Previous
Next ❯

Methods Mentioned

BETA
antisense oligonucleotide

Clinical Trials Mentioned

NCT01998841

Software Mentioned

Survival
Circos
Prodlim
R

Related Concepts

Related Feeds

ALS: Genetics

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating genetic alterations in this genetically heterogeneous disorder.

ALS: Genetics

Amyotrophic Lateral Sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

Amyloid Lateral Sclerosis

Amyotrophic Lateral Sclerosis (ALS) is a progressive nervous system disease associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.